Key result
In drivers with type 1 diabetes, driving during hypoglycemic states (<70 mg/dL) was significantly associated with increased at-risk vehicle acceleration behavior compared to driving during normal glucose levels.
Why the study?
Driver-state detection using wearable and in-vehicle sensor measurements of driver physiology and health is needed to quantify real-world driving behavior in at-risk drivers.
Does real-time glycemic state affect real-world driving behavior in drivers with insulin-dependent type 1 diabetes compared to drivers without diabetes?
Observational (n=33)
No
Does real-time glycemic state affect real-world driving behavior in drivers with insulin-dependent type 1 diabetes compared to drivers without diabetes?
Effect estimate: b = -0.38
p-value: p=<0.0001
Real-world driving behavior in drivers with type 1 diabetes changes significantly during at-risk glycemic states (hypoglycemia and severe hyperglycemia), highlighting the potential for wearable physiologic sensors to detect driver impairment.
Sensor-based monitoring feasible in T1DM drivers; leaves open validation for crash-risk reduction in clinical practice.
Our goal is to address the need for driver-state detection using wearable and in-vehicle sensor measurements of driver physiology and health. To address this goal, we deployed in-vehicle systems, wearable sensors, and procedures capable of quantifying real-world driving behavior and performance in at-risk drivers with insulin-dependent type 1 diabetes mellitus (DM). We applied these methodologies over 4 weeks of continuous observation to quantify differences in real-world driver behavior profiles associated with physiologic changes in drivers with DM (N=19) and without DM (N=14). Results showed that DM driver behavior changed as a function of glycemic state, particularly hypoglycemia. DM drivers often drive during at-risk physiologic states, possibly due to unawareness of impairment, which in turn may relate to blunted physiologic responses (measurable heart rate) to hypoglycemia after repeated episodes of hypoglycemia. We found that this DM driver cohort has an elevated risk of crashes and citations, which our results suggest is linked to the DM driver's own momentary physiology. Overall, our findings demonstrate a clear link between at-risk driver physiology and real-world driving. By discovering key relationships between naturalistic driving and parameters of contemporaneous physiologic changes, like glucose control, this study directly advances the goal of driver-state detection through wearable physiologic sensors as well as efforts to develop "gold standard" metrics of driver safety and an individualized approach to driver health and wellness.
No takes yet. Share an insight, caveat, or question.
Merickel et al. (2019) conducted an observational in Type 1 Diabetes Mellitus (n=33). Hypoglycemia and severe hyperglycemia (glycemic state) vs. Normal glucose levels (euglycemia) and drivers without DM was evaluated on Vehicle acceleration variability (at-risk driving behavior) (b = -0.38, p=<0.0001). In drivers with type 1 diabetes, driving during hypoglycemic states (<70 mg/dL) was significantly associated with increased at-risk vehicle acceleration behavior compared to driving during normal glucose levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: